title: Diabetes prediction, lipid accumulation product, and adiposity measures; 6-year follow-up: Tehran lipid and glucose study.
abstract: BACKGROUND
  The body mass index (BMI) is the most commonly used marker for evaluating obesity related risks, however, central obesity measures have been proposed to be more informative. Lipid accumulation product (LAP) is an alternative continuous index of lipid accumulation, which is computed from waist circumference (WC, cm) and triglycerides (TGs, mmol/l): (WC-65) xTG (men) and (WC-58) xTG (women). We sought in this study to assess if LAP can outperform BMI, waist-to-height-ratio (WHtR), or waist-to-hip-ratio (WHpR) in identifying prevalent and predicting incident diabetes.
  
  
  RESULTS
  The cross-sectional analyses were performed on a sample included 3,682 men and 4,989 women who were not pregnant, aged > or = 20 years. According to the age (> or = 50 and <50 years) - and sex-specific analyses, odds ratios (ORs) of LAP for prevalent diabetes were higher than those of BMI, WHpR, or WHtR among women, after adjustment for mean arterial pressure and family history of diabetes. The OR of LAP in old men was lower than those of other adiposity measures; in young men, however, LAP was superior to BMI but identical to WHpR and WHtR in identifying prevalent diabetes. Except in young men, LAP showed highest area under the receiver operating characteristic curves (AROC) for prevalent diabetes (P for trend < or = 0.005). For longitudinal analyses, a total of 5,018 non-diabetic subjects were followed for approximately 6 years. The ORs of BMI, WHpR, and WHtR were the same as those of LAP in both sexes and across age groups; except in young men where LAP was superior to the BMI. AROCs of LAP were relatively the same as anthropometric adiposity measures.
  
  
  CONCLUSIONS
  LAP was a strong predictor of diabetes and in young individuals had better predictability than did BMI; it was, however, similar to WHpR and WHtR in prediction of incident diabetes.
authors.affiliation: Prevention of Metabolic Disorders Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University, Tehran, Iran.
authors.forename: Mohammadreza
authors.initials: M
authors.lastname: Bozorgmanesh
authors.forename: Farzad
authors.initials: F
authors.lastname: Hadaegh
authors.forename: Fereidoun
authors.initials: F
authors.lastname: Azizi
mesh_terms: D050154:Adiposity; D000293:Adolescent; D000367:Age Factors; D015992:Body Mass Index; D003430:Cross-Sectional Studies; D003924:Diabetes Mellitus, Type 2 / Q000150:complications / Q000175:diagnosis* / Q000453:epidemiology*; D005260:Female; D005947:Glucose / Q000378:metabolism; D006801:Humans; D007492:Iran / Q000453:epidemiology; D050356:Lipid Metabolism; D008137:Longitudinal Studies; D008297:Male; D008875:Middle Aged; D011237:Predictive Value of Tests; D012737:Sex Factors; D055105:Waist Circumference; D049629:Waist-Hip Ratio; D055815:Young Adult
chemical_list: D005947:Glucose
references.citation: Ann Epidemiol. 2005 Feb;15(2):87-97
references.pmid: 15652713
references.citation: Int J Obes Relat Metab Disord. 2004 Mar;28(3):402-9
references.pmid: 14724659
references.citation: Obesity (Silver Spring). 2006 Jul;14(7):1274-81
references.pmid: 16899809
references.citation: Int J Obes Relat Metab Disord. 1997 Jul;21(7):587-93
references.pmid: 9226490
references.citation: Trends Endocrinol Metab. 2003 Nov;14(9):398-403
references.pmid: 14580758
references.citation: Obesity (Silver Spring). 2008 Jul;16(7):1622-35
references.pmid: 18421260
references.citation: Can J Appl Physiol. 2001 Jun;26(3):273-90
references.pmid: 11441231
references.citation: Int J Epidemiol. 2006 Feb;35(1):83-92
references.pmid: 16339600
references.citation: Diabetes Care. 2006 Aug;29(8):1921-3
references.pmid: 16873804
references.citation: Radiology. 1982 Apr;143(1):29-36
references.pmid: 7063747
references.citation: Curr Opin Lipidol. 2003 Jun;14(3):281-7
references.pmid: 12840659
references.citation: Diabetes Care. 2003 Nov;26(11):3160-7
references.pmid: 14578255
references.citation: Am J Epidemiol. 1998 Jan 1;147(1):49-58
references.pmid: 9440398
references.citation: Diabetes Care. 2009 May;32(5):956-8
references.pmid: 19196891
references.citation: Circulation. 2008 Feb 12;117(6):743-53
references.pmid: 18212285
references.citation: Diabetes Care. 2003 Sep;26(9):2556-61
references.pmid: 12941718
references.citation: Obesity (Silver Spring). 2009 Feb;17(2):342-8
references.pmid: 19008866
references.citation: Am J Clin Nutr. 2005 Mar;81(3):555-63
references.pmid: 15755822
references.citation: Endocrinology. 2003 Dec;144(12):5159-65
references.pmid: 12960011
references.citation: Diabetes Care. 2009 Nov;32 Suppl 2:S403-9
references.pmid: 19875589
references.citation: JAMA. 2008 Mar 12;299(10):1185-7
references.pmid: 18334695
references.citation: BMC Public Health. 2008 May 24;8:176
references.pmid: 18501007
references.citation: Control Clin Trials. 2000 Apr;21(2):127-37
references.pmid: 10715510
references.citation: Trials. 2009 Jan 25;10:5
references.pmid: 19166627
references.citation: Diabetologia. 2008 Jun;51(6):926-40
references.pmid: 18392804
references.citation: Am J Epidemiol. 1996 Feb 1;143(3):228-39
references.pmid: 8561156
references.citation: BMC Cardiovasc Disord. 2005 Sep 08;5:26
references.pmid: 16150143
references.citation: BMJ. 1998 Apr 18;316(7139):1236-8
references.pmid: 9553006
references.citation: Ann Intern Med. 2009 Jun 2;150(11):741-51
references.pmid: 19487709
references.citation: Ann Saudi Med. 2009 May-Jun;29(3):194-200
references.pmid: 19448363
references.citation: Am J Clin Nutr. 2004 Aug;80(2):475-82
references.pmid: 15277173
references.citation: Biometrics. 1988 Sep;44(3):837-45
references.pmid: 3203132
references.citation: Int J Obes (Lond). 2005 Sep;29(9):1011-29
references.pmid: 15925957
references.citation: Exp Clin Endocrinol Diabetes. 2006 Jun;114(6):310-5
references.pmid: 16868890
references.citation: Diabetes Care. 2006 Jan;29(1):151-3
references.pmid: 16373916